Sign in to follow this  
Followers 0
Guest Jude the Grouch

Canadian Health Authority Approves Thelin (Sitaxsentan Sodium) For Pulmonary Arterial Hypertension

1 post in this topic

Canadian Health Authority Approves THELIN (Sitaxsentan Sodium) for Pulmonary Arterial Hypertension. "THELIN has demonstrated a unique benefit for individuals who have developed PAH as a result of a connective tissue disease, such as scleroderma," said Janet Pope, M.D., Professor of Rheumatology, University of Western Ontario and Director, Division of Rheumatology, St. Joseph's Health Centre, London, Ontario. PrimeNewswire. Encysive Pharmaceuticals Inc. 05/30/07. (Also see: Pulmonary Hypertension and ISN: Dr. Janet Pope)

Share this post

Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
Sign in to follow this  
Followers 0